Tag: biotechnology
-
Crispr Heart Disease Start-Up Raises New $63M
A one year-old company developing a one-time gene-editing treatment for coronary artery disease is adding $63 million to its first venture funding round.
-
Cancer Drug Technology Licensed for Covid-19
A biotechnology company is licensing medical research discoveries from university labs first designed for treating cancer as a potential Covid-19 therapy.
-
Foundations Back ALS Biomarker Study
Two organizations supporting research on amyotrophic lateral sclerosis or ALS are funding a study of changes to chemical indicators in the body responding to ALS drugs.
-
Covid-19 Vaccine for Lower-Income Regions Underway
Researchers in the U.K. designed a vaccine to prevent Covid-19 infections and is starting an enterprise to make it available to lower-income countries.
-
Industry, Univ. Labs Partner on Covid-19 Therapy
Researchers from industry and academic labs are developing a synthetic antibody that in lab tests shows promise as both a Covid-19 therapy and vaccine.
-
DNA Bar Codes Added in Spores to Track Farm Products
Synthetic microbe spores made with unique DNA identifiers are shown to be capable of safely tracking vegetable crops from the farm to retail stores.
-
MD Anderson to Advance Laser Immunotherapy
An experimental cancer treatment that uses lasers to activate drugs that invoke the immune system is being evaluated by MD Anderson Cancer Center.
-
Start-Up Creating a Simpler, Stable Liquid Biopsy
A new company spun off from University of Oxford is developing a stable and sensitive blood test to detect multiple types of cancer in their early stages.
-
Fix Discovered for Gene Therapy Virus Delivery
Researchers in France and the U.S. discovered a bacterial enzyme that blocks immune reactions to otherwise benign viruses that deliver gene therapies.
-
Biotechs Apply Crispr Gene-Editing for Hemophilia
A treatment for the blood disease hemophilia and other inherited disorders are being developed with the gene-editing technology Crispr in a biotechnology deal.